Latest news

Latest news


How today’s coronavirus crisis will shape tomorrow’s regulatory landscape

Mar 25, 2020 Conduct

As the EU tightens the screws on isolation measures and local regulators devise unprecedented emergency plans, market participants reflect on the lessons that may be learnt from this crisis

SFTR delay: market relieved but stands ready

Mar 31, 2020 Compliance

Esma’s decision to grant a three-month forbearance to phase one firms has been largely welcomed, but market participants are reluctant to ease the pressure on their compliance efforts

Libor transition: Cross-currency deals continue to cause headaches

Mar 30, 2020 Conduct

Market participants have been unable to find a solution to this known problem area

Initial margin: firms look to optimise as phase 5 nears

Mar 26, 2020 Compliance

As the next phase of uncleared margin rules approach, many firms not currently affected are taking steps to avoid falling under its scope

Emir reporting: new guidelines are good but need wider takeup

Mar 26, 2020 Compliance

Industry associations Isda and the FIA recently published new best practice guidelines on Emir reporting, but their effect could be limited if not widely adopted

Market speculates on coronavirus-linked Libor delays

Mar 20, 2020 Conduct

With the virus situation rapidly escalating across the globe, Isda has already postponed its outstanding consultation on pre-cessation fallbacks. Other delays are likely to follow

Planned €STR June discounting switch will go ahead 

Mar 19, 2020 Compliance

Notwithstanding the domino effect that Covid-19 is already having on numerous areas of the financial market, European CCPs expect their discounting switch to be executed on time

Mifid II: IRPs battling to make research free

Mar 19, 2020 Conduct

Despite regulators’ actions, independent research providers are encouraging the buyside to use the free research they remain entitled to, including trials